Trial Profile
Use of Intraoperative Contrast-enhanced Ultrasound to Evaluate Femoral Head Perfusion in Infants With Developmental Dysplasia of the Hip at the Time of Surgical Reduction
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 22 May 2023
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Postoperative complications
- Focus Diagnostic use
- 13 Jun 2022 Planned End Date changed from 1 Apr 2027 to 1 Apr 2028.
- 13 Jun 2022 Planned primary completion date changed from 1 Apr 2024 to 1 Apr 2025.
- 11 Oct 2021 Planned number of patients changed from 35 to 125.